Skip Navigation LinksHome   |   Reference Center   |   Publication List
  • Print
  • Share

CIBMTR Publication List

Since 1972, use of CIBMTR data and statistical resources have resulted in more than 900 publications. These publications are organized by year below, and can be searched to help you quickly find the information you need. 

Display:



2016

Year Title Authors Publication
2016 Hematopoietic cell transplantation outcomes in monosomal karyotype myeloid malignancies. Pasquini MC, Zhang M-J, Medeiros BC, Armand P, Hu Z-H, Nishihori T, Aljurf MD, Akpek G, Cahn J-Y, Cairo MS, Cerny J, Copelan EA, Deol A, Freytes CO, Gale RP, Ganguly S, George B, Gupta V, Hale GA, Kamble RT, Klumpp TR, Lazarus HM, Luger SM, Liesveld JL, Litzow MR, Marks DI, Martino R, Norkin M, Olsson RF, Oran B, Pawarode A, Pulsipher MA, Ramanathan M, Reshef R, Saad AA, Saber W, Savani BN, Schouten HC, Ringdén O, Tallman MS, Uy GL, Wood WA Jr, Wirk B, Pérez WS, Batiwalla M, Weisdorf DJ Biol Blood Marrow Transplant 22(2):248-257
2016 Patient housing barriers to hematopoietic cell transplantation: results from a mixed-methods study of transplant center social workers. Preussler JM, Mau L-W, Majhail NS, Bevans M, Clancy E, Messner C, Parran L, Pederson KA, Ferguson SS, Walters W, Murphy EA, Denzen EM Support Care Cancer 24(3):1167-1174
2016 Infections following transplantation of bone marrow or peripheral-blood stem cells from unrelated donors. Young JAH, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER, Pergam SA, Marty FM, Strasfeld LM, Brown JM, Langston AA, Schuster MG, Kaul DR, Martin SI, Anasetti C Biol Blood Marrow Transplant 22(2):359-370
2016 Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions. Kumar R, Kimura F, Ahn KW, Hu Z-H, Kuwatsuka Y, Klein JP, Pasquini M, Miyamura K, Kato K, Yoshimi A, Inamoto Y, Ichinohe T, Wood WA Jr, Wirk B, Seftel M, Rowlings P, Marks DI, Schultz KR, Gupta V, Dedeken L, George B, Cahn J-Y, Szer J, Lee JW, Ho AY, Fasth A, Hahn T, Khera N, Dalal J, Bonfim C, Aljurf M, Atsuta Y, Saber W Biol Blood Marrow Transplant
2016 Global use of peripheral blood vs bone marrow as source of stem cells for allogeneic transplantation in patients with bone marrow failure. Yoshimi A, Baldomero H, Horowitz M, Szer J, Niederwieser D, Gratwohl A, Kodera Y JAMA 315(2):198-200
2016 Safety of ruxolitinib therapy prior to allogeneic hematopoietic stem-cell transplantation for myeloproliferative neoplasms. Hanif A, Hari PN, Atallah E, Carlson K-SB, Pasquini MC, Michaelis LC Bone Marrow Transplant
2016 The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis. Williams KM, Ahn KW, Chen M, Aljurf MD, Agwu AL, Chen AR, Walsh TJ, Szabolcs P, Boeckh MJ, Auletta JJ, Lindemans CA, Zanis-Neto J, Malvezzi M, Lister J, de Toledo Codina JS, Sackey K, Chakrabarty JLH, Ljungman P, Wingard JR, Seftel MD, Seo S, Hale GA, Wirk B, Smith MS, Savani BN, Lazarus HM, Marks DI, Ustun C, Abdel-Azim H, Dvorak CC, Szer J, Storek J, Yong A, Riches MR Bone Marrow Transplant
2016 GVHD after HLA-matched sibling BMT or PBSCT: comparison of North American Caucasian and Japanese populations. Kanda J, Brazauskas R, Hu ZH, Kuwatsuka Y, Nagafuji K, Kanamori H, Kanda Y, Miyamura K, Murata M, Fukuda T, Sakamaki H, Kimura F, Seo S, Aljurf M, Yoshimi A, Milone G, Wood WA, Ustun C, Hashimi S, Pasquini M, Bonfim C, Dalal J, Hahn T, Atsuta Y, Saber W Biol Blood Marrow Transplant
2016 Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes. Nakasone H, Sahaf B, Tian L, Wang T, Haagenson MD, Schoenrock K, Perloff S, Ryan CE, Wu F, Spellman SR, Lee SJ, Ritz J, Miklos DB Haematologica 101(1):e30-e33
2016 Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma. Klyuchnikov E, Bacher U, Woo Ahn K, Carreras J, Kröger NM, Hari PN, Ku GH, Ayala E, Chen AI, Chen Y-B, Cohen JB, Freytes CO, Gale RP, Kamble RT, Kharfan-Dabaja MA, Lazarus HM, Martino R, Mussetti A, Savani BN, Schouten HC, Usmani SZ, Wiernik PH, Wirk B, Smith SM, Sureda A, Hamadani M Bone Marrow Transplant 51(1):58-66
2016 Low socioeconomic status, adverse gene expression profiles, and clinical outcomes in hematopoietic stem cell transplant recipients. Knight JM, Rizzo JD, Logan BR, Wang T, Arevalo JMG, Ma J, Cole SW Clin Cancer Res 22(1):69-78
2016 Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. Ehrhardt MJ, Brazauskas R, He W, Rizzo JD, Shaw BE Bone Marrow Transplant 51(1):83-88
2016 Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902). Wood WA, Le Rademacher J, Syrjala KL, Jim H, Jacobsen PB, Knight JM, Abidi MH, Wingard JR, Majhail NS, Geller NL, Rizzo JD, Fei M, Wu J, Horowitz MM, Lee SJ Cancer 122(1):91-98
 
 
​​​​​

View current and planned studies
Last Updated: 8/20/2015 8:42 AM